PHARNEXT
"PHARNEXT" is a word mark owned by Pharnext, filed at the USPTO on May 10, 2019. It is registered and covers classes 5, 35, 41, 42 and 44.
- Status
- Registered
- Since June 2, 2020
- Filed
- May 10, 2019
- Registered
- June 2, 2020
- Expires
- Not recorded
- Application no.
- 88424864
- Registration no.
- 6066907
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 5 classes
Who owns PHARNEXT
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Pharnext
Issy-les-Moulineaux, France
Representative
Carlynn Ferguson Davis
Iphorgan Ltd.
What the mark covers
The products and services PHARNEXT is filed for, grouped by Nice class.
Medicine, namely, medicines for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; pharmaceutical products for human use for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; pharmaceutical preparations for human or veterinary use for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; biological preparations for medical purposes for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; diagnostic preparations for medical diagnosis purposes; chemical preparations for medical purposes, namely, for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; food supplements and nutritional supplements for medical purposes; dietetic foods and beverages adapted for medical and pharmaceutical purposes; homeopathic and phyto-therapeutic supplements; disinfectants for hygiene purposes for medicine; bath preparations for medical purposes; dietetic beverages adapted for medical purposes; chemical reagents for medical use, namely, biomarkers; products for personal hygiene for medical purposes, namely, medical soaps; plasters and gauze for dressings for medical purposes; medical dressings, except instruments
Creation, compilation and management of databases and central data files in the field of pharmaceutical research and development, medicine, genetics and clinical trials; compilation of statistics in the field of health and medicine; collection and systematization of data in a central file in the field of pharmaceutical research and development, health and medicine; public relations in the field of health and medicine
training services in the fields of health, pharmaceutical and medical research, pharmaceutical and medical development; publication of books and texts other than publicity texts in the pharmaceutical, medical and health fields; educational services, namely, arranging and conducting educational colloquiums, conferences, congresses, and seminars in the fields of pharmaceuticals, medical and health; teaching in the pharmaceutical, medical and health fields
pharmaceutical products development; pharmaceutical research and development; conducting tests on pharmaceutical products; conducting clinical trials for pharmaceutical products for others; scientific research in the field of medicine; bioinformatics, chemical and biological analysis; scientific research in chemistry, cosmetology, biology, bacteriology, nutrition, biotechnology; biological research and bioinformatics services in the field of chemical, biological and pharmaceutical products; software development and design in the field of pharmaceutical research, health and medicine; provision of scientific information relating to pharmaceutical products and medical and scientific research in the field of pharmaceuticals products and clinical trials; scientific research on chemical reagents for medical use, namely, biomarkers; pharmaceutical research services
medical services; pharmaceutical advice services; pharmacy consultation; medical advisory and information services relating to pharmaceutical products; medical information services; provision of medical information; providing health information services on the treatment of diseases through an awareness program
What has happened so far
Steps recorded by the USPTO, newest first.
- Courtesy reminder - sec. 8 (6-yr) e-mailed
- Assignment of ownership not updated automatically
- Assignment of ownership not updated automatically
- Registered-principal register
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Examiner's amendment entered
- Notification of examiners amendment e-mailed
10 earlier steps on the official record.
About PHARNEXT
Who owns the trademark "PHARNEXT"?
The USPTO trademark "PHARNEXT" (application 88424864) is owned by Pharnext.
What is the status of "PHARNEXT"?
Its status at the USPTO is: registered.
When was "PHARNEXT" registered?
It was registered on June 2, 2020.
Get this data via the API
Everything on this page comes from the Signa API. Pull PHARNEXT and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2a8d-4403-7125-8fbe-3a3ffd094b6c
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2a8d-4403-7125-8fbe-3a3ffd094b6c",
"object": "trademark",
"mark_text": "PHARNEXT",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "88424864",
"filing_date": "2019-05-10",
"nice_classes": [
5,
35,
41,
42,
44
],
"owners": [
{
"name": "PHARNEXT",
"entity_id": "ent_019eb711-d54c-741b-9968-8b3263f25cb4"
}
]
}